ArticleOncogene2026

Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition.

Meilin Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.